Coloplast A/S
CLPBF
$57.64
$0.360.62%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.91% | 0.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.91% | 0.69% | |||
| Cost of Revenue | 1.03% | 4.48% | |||
| Gross Profit | -1.86% | -1.06% | |||
| SG&A Expenses | -0.67% | 0.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -277.63% | 92.54% | |||
| Total Operating Expenses | -0.14% | 3.57% | |||
| Operating Income | -3.08% | -6.61% | |||
| Income Before Tax | -168.43% | 14.60% | |||
| Income Tax Expenses | -168.26% | -42.35% | |||
| Earnings from Continuing Operations | -168.47% | 58.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -168.47% | 58.86% | |||
| EBIT | -3.08% | -6.61% | |||
| EBITDA | 131.99% | -0.65% | |||
| EPS Basic | -168.41% | 59.15% | |||
| Normalized Basic EPS | -4.00% | 0.44% | |||
| EPS Diluted | -168.51% | 58.97% | |||
| Normalized Diluted EPS | -4.00% | 0.44% | |||
| Average Basic Shares Outstanding | 0.09% | -0.18% | |||
| Average Diluted Shares Outstanding | 0.09% | -0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | -- | |||